Modern Action logo
IssuesBillsBriefing
Donate
Donate
Modern Action

Navigation

Menu

01HomeFront page→02IssuesActive issue pages→03BillsLegislation index→04BriefingDaily context→05DonateSupport the work→

Account

Sign In→Get Started→
Modern Action

Find the bills behind the news, understand what Congress can do, and contact your representatives with a specific message.

Platform

  • Contact Congress
  • Write to Congress
  • Browse Bills
  • Track Bills

Resources

  • Find My Representatives
  • Contact My Representatives
  • How to Contact Representatives
  • Does Contacting Congress Work?

Support

  • Contact Us
  • Accessibility

Legal

  • Privacy Policy
  • Terms of Service
  • Cookie Policy
  • Accessibility

Stay informed about legislation

Get weekly updates on important bills and how to take action.

© 2026 Modern Action. All rights reserved.

Made with ❤️ for democracy
All systems operational

Contact Congress about H.R. 2636: Making Insulin Affordable for All Children Act

People age 26 and under with private health insurance would pay less for certain insulin products. Plans would have to cover selected insulin before the deductible and cap the monthly charge. The bill would start with plan years beginning on or after January 1, 2026.

Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

Making Insulin Affordable for All Children Act is a House bill in committee. The latest recorded action: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Latest action on H.R. 2636: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Who this affects: This bill mainly affects families with children, teens, or young adults who use insulin and have private health insurance. It also directly affects insurers, employer health plans, marketplace plans, pharmacy benefit managers that negotiate drug prices, and employers that help pay for coverage. People over 26 are much less affected because the bill's special cost limits do not apply to them unless another law does.

Why this matters: Insulin can be life-saving, but many families still face high and uneven costs depending on their health plan. This bill would put a national ceiling on what privately insured young people can be charged for certain insulin products. That could make costs easier to plan for and reduce pressure to delay or ration insulin. At the same time, the bill leaves open how plans will choose covered products and whether costs could shift into premiums or other parts of coverage.

Key provisions in H.R. 2636

  • This bill covers people age 26 or younger in private health insurance. That includes group plans, individual plans, and catastrophic plans.
  • Plans would have to cover at least one insulin product in each available form, such as a vial, pump, or inhaler. They would also have to cover at least one product in each main insulin type, such as rapid-acting, long-acting, and premixed, and label those as selected insulin products.
  • Plans could not make eligible young enrollees meet a deductible before getting a selected insulin product. This rule would start in plan years that begin on or after January 1, 2026.
  • What a patient pays for a selected insulin product would be capped for each 30-day supply. The limit would be the lower of $35 or 25% of the negotiated price after rebates and discounts, including deals worked out by pharmacy benefit managers.
  • Any amount paid under these insulin caps would still count toward the plan's deductible and yearly out-of-pocket maximum. So those payments would still help the patient reach the plan's usual financial limits.

How Modern Action helps you take action on H.R. 2636

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about H.R. 2636

What is H.R. 2636?
People age 26 and under with private health insurance would pay less for certain insulin products. Plans would have to cover selected insulin before the deductible and cap the monthly charge. The bill would start with plan years beginning on or after January 1, 2026.
How do I support or oppose H.R. 2636?
Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.
Who should I contact about H.R. 2636?
Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.
Can Modern Action explain H.R. 2636 before I act?
Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.

Keep acting on Modern Action

More ways to act on this issue

Compare the broader issue and related bills without leaving Modern Action.

Related issues

  • Contact your reps on Insulin costs in private health plansPrivate health plans should limit what young people pay for insulin.
  • Contact your reps on Insulin pricing and copay capsImplementing and enforcing caps on insulin prices and copays to ensure affordability.

Related bills

  • Take action on H.R. 3546: Prescription Drug Price Relief Act of 2025
  • Take action on H.R. 6166: Lowering Drug Costs for American Families Act
  • Take action on H.R. 6255: Affordable Insulin Now Act